Novavax’s CEO, Board Sued For Misleading Investors Over COVID-19 Vaccine
GREENBELT, Md. — An investor filed a shareholder derivative lawsuit against several executives officers and directors of biopharmaceutical company Novavax Inc. in Maryland federal court on Nov. 22, alleging that the...To view the full article, register now.
Already a subscriber? Click here to view full article